Recurrent Non-small Cell Lung Cancer Recruiting Phase 1 Trials for Erlotinib (DB00530)

Also known as: Non-Small Cell Lung Cancer Recurrent / Lung cancer non-small cell recurrent

IndicationStatusPhase
DBCOND0028805 (Recurrent Non-small Cell Lung Cancer)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs